Immune Therapeutics, Inc. Stock Other OTC
Equities
IMUN
US45252A1079
Biotechnology & Medical Research
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 6.11M |
---|---|---|---|---|---|
Net income 2022 | -3M | Net income 2023 | -1M | EV / Sales 2022 | - |
Net Debt 2022 | 546K | Net Debt 2023 | 1.15M | EV / Sales 2023 | - |
P/E ratio 2022 |
-6
x | P/E ratio 2023 |
-3.65
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.72% |
Managers | Title | Age | Since |
---|---|---|---|
Noreen Griffin
FOU | Founder | 71 | 93-12-01 |
Glen Farmer
DFI | Director of Finance/CFO | 55 | 22-08-01 |
Robert Wilson
BRD | Director/Board Member | 51 | 22-05-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Wilson
BRD | Director/Board Member | 51 | 22-05-30 |
Mary Caperton
BRD | Director/Board Member | 62 | 23-10-23 |
Roger Suro
BRD | Director/Board Member | 50 | Nov. 07 |
1st Jan change | Capi. | |
---|---|---|
+20.95% | 127B | |
+23.00% | 116B | |
+25.15% | 27.69B | |
-19.75% | 19.62B | |
-16.57% | 16.26B | |
-16.56% | 15.49B | |
+11.19% | 14.81B | |
-46.65% | 14.39B | |
+57.74% | 14.11B |